One challenge for innovators at MSK and elsewhere is that technology development is costly and funding options are limited—especially once the potential for federal grant funding has been exhausted.

Hyperautomation and the move to optimize business processes are fueling uptake and sales for low-code development technologies, which will grow by 19% over the next four years to reach $44.5 billion ...